NCT01538576已完成不适用
Special Survey for Paediatric Subjects
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 71
- 主要终点
- Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control
研究概览
简要总结
This study is conducted in Japan. The aim of this study is to collect safety and efficacy data when using insulin aspart in children with diabetes under normal clinical practice conditions.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 15 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with diabetes requiring insulin therapy
排除标准
- •Subjects who had treatment history of insulin aspart
研究组 & 干预措施
Insulin aspart users
干预措施: insulin aspart (Drug)
结局指标
主要结局
Response rate assessed by the investigator: Ability or failure to achieve expected glycaemic control
时间窗: Year 1
HbA1c (glycosylated haemoglobin)
时间窗: Year 1
次要结局
- Hypoglycaemic events(Year 1)
- Adverse Events(Year 1)
研究者
相似试验
已完成
不适用
Special Survey for Paediatric SubjectsDiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2NCT01487382Novo Nordisk A/S241
已完成
3 期
A Phase3 Study to Evaluate the Efficacy and Safety of MEDI3250 in Healthy Japanese Children Age 7 Years Through 18 YearsHealthy Japanese Children Age 7 Years Through 18 YearsNCT02269475AstraZeneca1,369
已完成
3 期
BMS-188667 in Children and Adolescents With Juvenile Rheumatoid ArthritisJuvenile Rheumatoid ArthritisNCT00095173Bristol-Myers Squibb214
已完成
不适用
Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner SyndromeGrowth Hormone Deficiency in ChildrenGrowth Hormone DisorderGenetic DisorderTurner SyndromeNCT01604161Novo Nordisk A/S2,016
已完成
不适用
Study to Evaluate Overall Survival in Japanese Patients With HR+/HER2- Advanced Breast Cancer Treated With Palbociclib Plus LetrozoleBreast CancerNCT04735367Pfizer42